The Peptide Promise With NervGen's Mike Kelly

Business Of Biotech - Podcast autorstwa Matt Pillar - Poniedziałki

Kategorie:

We love to hear from our listeners. Send us a message. Mike Kelly faced a self-reckoning before he took the job as CEO at NervGen, a company developing peptide therapeutics targeted specifically at central nervous system repair. The veteran of life sciences business development knew the ropes of the biotech C-suite. He’d been a CEO twice before. He knew how to launch drugs, having seen commercial success several times before. He even knew how to sell them—he’d started his career carrying the...

Visit the podcast's native language site